Therapeutic Efficacy of Triple Combination in Drug-naïve Korean Type 2 Diabetic Patients
Status:
Completed
Trial end date:
2018-09-01
Target enrollment:
Participant gender:
Summary
Triple combination of metformin, DPP4 inhibitor and Thiazolidinedione would be a good option
in the treatment of drug-naïve Korean type 2 diabetic patients.